Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Rivaroxaban
- Therapeutic area
- Hematology & thrombosis
- Drug class
- Anticoagulants
- ATC
- B01AF
- Strength
- 2.5 mg
- Dosage form
- Tablet
- Pack
- 10's
- Registration no.
- 090988
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-10-09 03:22
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →About Xcept 2.5 mg tablet
Xcept 2.5 mg tablet contains Rivaroxaban 2.5 mg. It is registered with DRAP by PHARMEVO (PVT) LTD (registration no. 090988). Its official price is PKR 1,932.97 for a pack of 10's, about PKR 193.30 per tablet. This price has applied since 4 August 2025. Xcept is also available as 10 mg tablet, 15 mg tablet and 20 mg tablet. 15 other brands of Rivaroxaban 2.5 mg (tablet) are registered in Pakistan. Compare all brands and prices →
Other strengths of Xcept
Other brands of Rivaroxaban 2.5 mg
Official price over time
No change in the official DRAP price is recorded for this pack (10's). Current price PKR 1,932.97, effective 4 Aug 2025.
Cite this price history
MedInfoBase. Xcept 2.5 mg, 10's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/xcept-2-5-mg-090988-10s-pharmevo-pvt-ltd/ (accessed 9 October 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 1,932.97 | 2025-08-04 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 090988Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.
